Understanding Common Sexually Transmitted Infections and UTIs

Urinary Tract Infection (UTI) with Escherichia coli (E. coli)

E. coli is a common cause of UTI.

Risk Factors, Pathogenesis, and Clinical Manifestations

Risk Factors: Female gender, sexual activity, urinary stasis, catheter use, and diabetes.

Pathogenesis:

  1. Introduction of E. coli (usually from the gastrointestinal tract)
  2. Colonization of the urethra (via urethral opening)
  3. Adherence to uroepithelial cells (via fimbriae)
  4. Invasion of the bladder (Cystitis)
  5. Inflammation and immune response
  6. Symptoms of UTI (dysuria, frequency, urgency, pain)

Clinical Manifestations: Increased urinary frequency, suprapubic pain, hematuria, or fever.

Laboratory Diagnosis

  1. Urine Culture:
    • Gold standard for diagnosing UTI.
    • Urine sample is cultured on MacConkey agar, where E. coli produces lactose-fermenting pink colonies.
    • Growth of >105 CFU/mL of bacteria in the urine is indicative of infection.
  2. Microscopic Examination:
    • A wet mount or Gram stain of the urine sediment is examined.
    • Pyuria (presence of white blood cells) is common, indicative of inflammation.
    • Bacteriuria (presence of bacteria) confirms infection.
    • Hematuria (blood in urine) can also be observed.
  3. Urinalysis:
    • Leukocyte Esterase Test: Detects the presence of WBCs, confirming inflammation.
    • Nitrite Test: E. coli reduces nitrates to nitrites, making this test positive.
    • pH and Protein: Urine may be slightly acidic with mild proteinuria.
    • Microscopic hematuria might be noted due to bladder irritation.
  4. Antibiotic Sensitivity Testing:
    • After identifying the organism, antibiotic susceptibility is tested.
    • Common methods include disk diffusion (Kirby-Bauer test) or MIC (Minimum Inhibitory Concentration) determination.
  5. Additional Tests:
    • Blood Cultures: If systemic infection or sepsis is suspected.
    • Ultrasound: To check for hydronephrosis or renal involvement.

Treatment

Ciprofloxacin or amoxicillin may be used.

Chlamydia trachomatis Infection

Likely causing nongonococcal urethritis.

Other Manifestations of Chlamydia trachomatis Infection

  • Pelvic inflammatory disease (PID)
  • Cervicitis
  • Epididymitis
  • Conjunctivitis
  • Reiter’s syndrome (reactive arthritis)

Laboratory Diagnosis

  • Microscopy: Detection of inclusion bodies in cells stained with Lugol’s iodine, which are characteristic of Chlamydia trachomatis.
  • Nucleic acid amplification tests (NAATs): These are the most sensitive tests for detecting Chlamydia DNA or RNA from urine, urethral, or cervical swabs.
  • Culture: The bacteria can be cultured in specialized cell lines, though it is not commonly done due to time and resource constraints.
  • Direct fluorescence antibody (DFA): Fluorescent-labeled antibodies can be used to identify the bacteria in specimens.

Primary Syphilis

The probable etiological agent is Treponema pallidum, a spirochete bacterium.

Risk Factors and Pathogenesis

Risk Factors:

  • Unprotected sexual contact (especially with multiple or high-risk partners like commercial sex workers)
  • Male-to-male sexual contact
  • HIV infection, which increases susceptibility
  • Lack of condom use

Pathogenesis:

Treponema pallidum enters the body through mucous membranes or broken skin during sexual contact. It then invades the bloodstream and spreads to various organs.

Clinical Manifestations

  • Primary syphilis: A painless, indurated ulcer (chancre) at the site of infection, usually genital, anal, or oral. It typically heals spontaneously in 3–6 weeks but leaves the bacteria in the body.
  • Enlarged inguinal lymph nodes (due to regional infection).
  • Secondary syphilis can follow if untreated, characterized by skin rashes, mucous patches, and systemic involvement.

Laboratory Diagnosis

  • VDRL (Venereal Disease Research Laboratory) / RPR (Rapid Plasma Reagin): Reactive test as seen in the case, indicating syphilis infection.
  • Dark-field microscopy: Direct visualization of Treponema pallidum from the chancre.
  • FTA-ABS (Fluorescent Treponemal Antibody Absorption Test): Confirmatory test to detect specific antibodies against Treponema pallidum.

Treatment and Prophylaxis

Treatment:

  • Penicillin G (intramuscular, single dose) is the first-line treatment for all stages of syphilis.
  • Alternative antibiotics like doxycycline or azithromycin can be used in penicillin-allergic individuals.

Prophylaxis:

  • Safe sexual practices (use of condoms) to reduce transmission.
  • Regular screening for sexually active individuals, especially those with multiple partners or high-risk behavior.
  • Early treatment of infected individuals to prevent progression and transmission to others.

Gonococcal Urethritis

The probable etiological agent is Neisseria gonorrhoeae, a Gram-negative diplococcus.

Risk Factors and Pathogenesis

Risk Factors:

  • Unprotected sexual contact, especially with high-risk partners like commercial sex workers.
  • Multiple sexual partners or a history of sexually transmitted infections (STIs).
  • Men who have sex with men (MSM).

Pathogenesis:

  1. Entry via mucous membranes
  2. Adherence to epithelial cells
    • Pili allow attachment to the urethral and genital mucosal surfaces
  3. Penetration of epithelial cells
    • Bacteria invade and enter host cells
  4. Invasion of submucosal tissues
    • Bacteria spread to deeper tissues causing inflammation
  5. Immune evasion
    • Bacteria evade the immune system by varying surface proteins (antigenic variation)
  6. Localized inflammation
    • Leads to symptoms like dysuria, urethral discharge, and pain
  7. Potential complications
    • In men: Epididymitis, prostatitis
    • In women: Pelvic inflammatory disease (PID), cervicitis

Clinical Manifestations

  • Urethral discharge (typically yellow or green) and dysuria.
  • In men, may lead to epididymitis or prostatitis if untreated.
  • In women, cervicitis and potential complications like pelvic inflammatory disease (PID).

Laboratory Diagnosis

  • Gram stain: Pus cells with intracellular Gram-negative diplococci seen under the microscope.
  • Culture: On modified Thayer-Martin medium, which supports the growth of Neisseria gonorrhoeae while inhibiting other organisms. Colonies are small, convex, and translucent.
  • NAAT (Nucleic Acid Amplification Test): A highly sensitive method for detecting gonococcal DNA from urine or swabs, often used as a confirmatory test.

Treatment

  • Ceftriaxone 250 mg intramuscularly as a single dose
  • Azithromycin (or doxycycline) is often co-administered to treat potential chlamydial co-infection.